Verition Fund Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34,098	Closed	-$59K	–	2921
2024 Q4	$59K	Buy	+34,098	New	+$59K	﹤0.01%	2453
2023 Q4	–	Sell	-85,034	Closed	-$269K	–	2220
2023 Q3	$269K	Buy	+85,034	New	+$269K	﹤0.01%	1482